Bone formation of middle ear cavity using biphasic calcium phosphate lyophilized with Escherichia coli-derived recombinant human bone morphogenetic protein 2 using animal model

Sung Eun Kim, Young Pil Yun, Hae Ryong Song, Kyung Hee Choi, Bo Hae Kim, Eun Kyeung Lee, Jae-Jun Song

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: The aim of the study was to analyze the value of Escherichia coli-derived recombinant human bone morphogenetic protein-2 (ErhBMP-2) coated biphasic calcium phosphate (BCP) for the obliteration of middle ear bone defect after mastoid surgery. Methods: Twenty-four specific pathogen-free Sprague-Dawley rats were randomly assigned to the BCP group ( n= 12) and BCP-ErhBMP-2 group ( n= 12; in which BCP scaffold of the granular type was coated with ErhBMP-2). In both groups, BCP scaffold was used to surgically fill the middle ear bulla. New bone formation was evaluated by measuring bone density (%) after 4 and 8 weeks in all rats in both groups. Results: At 4 weeks, new bone was visible at the periphery and center of the middle ear cavity in both groups. In the BCP group, a moderate amount of fibrous tissue had infiltrated into the interspace of the scaffolds. New bone almost totally filled the interspace in the BCP-ErhBMP-2 group. At 8 weeks, copious new bone formation had occurred. Histometric measurements showed that bone density in the BCP group was smaller than in the BCP-ErhBMP-2 group at 4 weeks (25.10% and 38.43%, respectively; p<. 0.05) and 8 weeks (25.54% and 34.18%, respectively; p<. 0.05). Conclusions: New bone formation was greater in the presence of BCP-ErhBMP-2 scaffolds. ErhBMP-2 coated BCP scaffolds is a potentially useful material for middle ear obliteration after mastoidectomy.

Original languageEnglish
Pages (from-to)1430-1433
Number of pages4
JournalInternational Journal of Pediatric Otorhinolaryngology
Volume77
Issue number9
DOIs
Publication statusPublished - 2013 Sep 1

Fingerprint

Middle Ear
Osteogenesis
Animal Models
Escherichia coli
Bone and Bones
Bone Density
hydroxyapatite-beta tricalcium phosphate
recombinant human bone morphogenetic protein-2
Specific Pathogen-Free Organisms
Mastoid
Blister
Sprague Dawley Rats

Keywords

  • Bone morphogenetic protein
  • Mastoid obliteration
  • Otitis media
  • Scaffold

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Pediatrics, Perinatology, and Child Health

Cite this

Bone formation of middle ear cavity using biphasic calcium phosphate lyophilized with Escherichia coli-derived recombinant human bone morphogenetic protein 2 using animal model. / Kim, Sung Eun; Yun, Young Pil; Song, Hae Ryong; Choi, Kyung Hee; Kim, Bo Hae; Lee, Eun Kyeung; Song, Jae-Jun.

In: International Journal of Pediatric Otorhinolaryngology, Vol. 77, No. 9, 01.09.2013, p. 1430-1433.

Research output: Contribution to journalArticle

@article{9af56ebc77604e67ad41fd3fa3760084,
title = "Bone formation of middle ear cavity using biphasic calcium phosphate lyophilized with Escherichia coli-derived recombinant human bone morphogenetic protein 2 using animal model",
abstract = "Objective: The aim of the study was to analyze the value of Escherichia coli-derived recombinant human bone morphogenetic protein-2 (ErhBMP-2) coated biphasic calcium phosphate (BCP) for the obliteration of middle ear bone defect after mastoid surgery. Methods: Twenty-four specific pathogen-free Sprague-Dawley rats were randomly assigned to the BCP group ( n= 12) and BCP-ErhBMP-2 group ( n= 12; in which BCP scaffold of the granular type was coated with ErhBMP-2). In both groups, BCP scaffold was used to surgically fill the middle ear bulla. New bone formation was evaluated by measuring bone density ({\%}) after 4 and 8 weeks in all rats in both groups. Results: At 4 weeks, new bone was visible at the periphery and center of the middle ear cavity in both groups. In the BCP group, a moderate amount of fibrous tissue had infiltrated into the interspace of the scaffolds. New bone almost totally filled the interspace in the BCP-ErhBMP-2 group. At 8 weeks, copious new bone formation had occurred. Histometric measurements showed that bone density in the BCP group was smaller than in the BCP-ErhBMP-2 group at 4 weeks (25.10{\%} and 38.43{\%}, respectively; p<. 0.05) and 8 weeks (25.54{\%} and 34.18{\%}, respectively; p<. 0.05). Conclusions: New bone formation was greater in the presence of BCP-ErhBMP-2 scaffolds. ErhBMP-2 coated BCP scaffolds is a potentially useful material for middle ear obliteration after mastoidectomy.",
keywords = "Bone morphogenetic protein, Mastoid obliteration, Otitis media, Scaffold",
author = "Kim, {Sung Eun} and Yun, {Young Pil} and Song, {Hae Ryong} and Choi, {Kyung Hee} and Kim, {Bo Hae} and Lee, {Eun Kyeung} and Jae-Jun Song",
year = "2013",
month = "9",
day = "1",
doi = "10.1016/j.ijporl.2013.05.035",
language = "English",
volume = "77",
pages = "1430--1433",
journal = "International Journal of Pediatric Otorhinolaryngology",
issn = "0165-5876",
publisher = "Elsevier Ireland Ltd",
number = "9",

}

TY - JOUR

T1 - Bone formation of middle ear cavity using biphasic calcium phosphate lyophilized with Escherichia coli-derived recombinant human bone morphogenetic protein 2 using animal model

AU - Kim, Sung Eun

AU - Yun, Young Pil

AU - Song, Hae Ryong

AU - Choi, Kyung Hee

AU - Kim, Bo Hae

AU - Lee, Eun Kyeung

AU - Song, Jae-Jun

PY - 2013/9/1

Y1 - 2013/9/1

N2 - Objective: The aim of the study was to analyze the value of Escherichia coli-derived recombinant human bone morphogenetic protein-2 (ErhBMP-2) coated biphasic calcium phosphate (BCP) for the obliteration of middle ear bone defect after mastoid surgery. Methods: Twenty-four specific pathogen-free Sprague-Dawley rats were randomly assigned to the BCP group ( n= 12) and BCP-ErhBMP-2 group ( n= 12; in which BCP scaffold of the granular type was coated with ErhBMP-2). In both groups, BCP scaffold was used to surgically fill the middle ear bulla. New bone formation was evaluated by measuring bone density (%) after 4 and 8 weeks in all rats in both groups. Results: At 4 weeks, new bone was visible at the periphery and center of the middle ear cavity in both groups. In the BCP group, a moderate amount of fibrous tissue had infiltrated into the interspace of the scaffolds. New bone almost totally filled the interspace in the BCP-ErhBMP-2 group. At 8 weeks, copious new bone formation had occurred. Histometric measurements showed that bone density in the BCP group was smaller than in the BCP-ErhBMP-2 group at 4 weeks (25.10% and 38.43%, respectively; p<. 0.05) and 8 weeks (25.54% and 34.18%, respectively; p<. 0.05). Conclusions: New bone formation was greater in the presence of BCP-ErhBMP-2 scaffolds. ErhBMP-2 coated BCP scaffolds is a potentially useful material for middle ear obliteration after mastoidectomy.

AB - Objective: The aim of the study was to analyze the value of Escherichia coli-derived recombinant human bone morphogenetic protein-2 (ErhBMP-2) coated biphasic calcium phosphate (BCP) for the obliteration of middle ear bone defect after mastoid surgery. Methods: Twenty-four specific pathogen-free Sprague-Dawley rats were randomly assigned to the BCP group ( n= 12) and BCP-ErhBMP-2 group ( n= 12; in which BCP scaffold of the granular type was coated with ErhBMP-2). In both groups, BCP scaffold was used to surgically fill the middle ear bulla. New bone formation was evaluated by measuring bone density (%) after 4 and 8 weeks in all rats in both groups. Results: At 4 weeks, new bone was visible at the periphery and center of the middle ear cavity in both groups. In the BCP group, a moderate amount of fibrous tissue had infiltrated into the interspace of the scaffolds. New bone almost totally filled the interspace in the BCP-ErhBMP-2 group. At 8 weeks, copious new bone formation had occurred. Histometric measurements showed that bone density in the BCP group was smaller than in the BCP-ErhBMP-2 group at 4 weeks (25.10% and 38.43%, respectively; p<. 0.05) and 8 weeks (25.54% and 34.18%, respectively; p<. 0.05). Conclusions: New bone formation was greater in the presence of BCP-ErhBMP-2 scaffolds. ErhBMP-2 coated BCP scaffolds is a potentially useful material for middle ear obliteration after mastoidectomy.

KW - Bone morphogenetic protein

KW - Mastoid obliteration

KW - Otitis media

KW - Scaffold

UR - http://www.scopus.com/inward/record.url?scp=84882620081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882620081&partnerID=8YFLogxK

U2 - 10.1016/j.ijporl.2013.05.035

DO - 10.1016/j.ijporl.2013.05.035

M3 - Article

VL - 77

SP - 1430

EP - 1433

JO - International Journal of Pediatric Otorhinolaryngology

JF - International Journal of Pediatric Otorhinolaryngology

SN - 0165-5876

IS - 9

ER -